TY  - GEN

T1  - Evaluating the cost-effectiveness of the addition of rituximab to chemotherapy in the first-line treatment of Follicular Lymphoma patients in the UK

PY  - -0001/11/30

AU  - Rafia R

AU  - Papaioannou D

AU  - Stevenson M

AU  - Rathbone J

AU  - Woods H

ED  - 

Y2  - 2024/09/20

ER  -